These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19342954)

  • 21. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis.
    Katchamart W; Bombardier C
    J Rheumatol; 2010 Jul; 37(7):1411-5. PubMed ID: 20436069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S237-51. PubMed ID: 18095787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease.
    Sierakowski S; Cutolo M
    Scand J Rheumatol Suppl; 2011; 125():1-5. PubMed ID: 21529303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular disease in rheumatoid arthritis: a step forward.
    Myasoedova E; Gabriel SE
    Curr Opin Rheumatol; 2010 May; 22(3):342-7. PubMed ID: 20164773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonpharmacological interventions for the treatment of rheumatoid arthritis: a focus on mind-body medicine.
    Leverone D; Epstein BJ
    J Pharm Pract; 2010 Apr; 23(2):101-9. PubMed ID: 21507802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of established rheumatoid arthritis with an emphasis on pharmacotherapy.
    Blom M; van Riel PL
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):43-57. PubMed ID: 17350543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2008 Apr; 14(4):234-54. PubMed ID: 18415967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care.
    Castrejón I; Pincus T
    Bull NYU Hosp Jt Dis; 2011; 69(2):104-10. PubMed ID: 22035388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can observational studies replace or complement experiment?
    van der Linden S; Goldsmith CH; Woodcock J; Nassonova V
    J Rheumatol Suppl; 1994 Sep; 41():57-61. PubMed ID: 7799388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
    Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
    Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome.
    Schipper LG; van Hulst LT; Grol R; van Riel PL; Hulscher ME; Fransen J
    Rheumatology (Oxford); 2010 Nov; 49(11):2154-64. PubMed ID: 20671022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic consequences of established rheumatoid arthritis and its treatment.
    Kavanaugh A
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):929-42. PubMed ID: 17870036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total ankle replacement for rheumatoid ankle arthritis.
    Wood PL; Crawford LA; Suneja R; Kenyon A
    Foot Ankle Clin; 2007 Sep; 12(3):497-508, vii. PubMed ID: 17765841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-reported outcomes in rheumatoid arthritis.
    Her M; Kavanaugh A
    Curr Opin Rheumatol; 2012 May; 24(3):327-34. PubMed ID: 22410543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.
    Pincus T
    Bull NYU Hosp Jt Dis; 2008; 66(3):216-23. PubMed ID: 18937635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of MRI in rheumatoid arthritis: research and clinical issues.
    Freeston JE; Bird P; Conaghan PG
    Curr Opin Rheumatol; 2009 Mar; 21(2):95-101. PubMed ID: 19339918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
    Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
    J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are early arthritis clinics necessary?
    Quinn MA; Emery P
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):1-17. PubMed ID: 15588968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Management of early rheumatoid arthritis].
    Iking-Konert C; Ostendorf B; Schneider M
    Med Monatsschr Pharm; 2007 Mar; 30(3):94-100; quiz 101. PubMed ID: 17405482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.